Summary
This is a forecasted federal funding opportunity (U01 cooperative agreement) issued by the FDA under HHS. It is focused on health equity innovation, specifically aimed at enhancing equity in health-related research or programs. Clinical trials are explicitly not allowed under this funding mechanism. The opportunity was forecasted as of August 2024 and full details are pending formal publication.